XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS’ (DEFICIT) EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Loans to Related Parties
Accumulated Deficit
Beginning balance (in shares) at Dec. 27, 2020   62,562,051 16,731,625      
Beginning balance at Dec. 27, 2020 $ (307,362) $ 505,638 $ 17 $ 19,662 $ (4,000) $ (323,041)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (56,928)         (56,928)
Exercise of stock options (in shares) 904,159   904,159      
Exercise of stock options $ 3,763   $ 1 3,762    
Stock-based compensation expense 3,099     3,099    
Issuance of preferred stock (net of issuance costs) (in shares)   6,669,146        
Issuance of preferred stock (net of issuance costs) 0 $ 108,858        
Ending balance (in shares) at Jun. 27, 2021   69,231,197 17,635,784      
Ending balance at Jun. 27, 2021 (357,428) $ 614,496 $ 18 26,523 (4,000) (379,969)
Beginning balance (in shares) at Mar. 28, 2021   69,231,197 17,293,090      
Beginning balance at Mar. 28, 2021 (333,662) $ 614,496 $ 18 23,406 (4,000) (353,086)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (26,883)         (26,883)
Exercise of stock options (in shares)     342,694      
Exercise of stock options 1,240     1,240    
Stock-based compensation expense 1,877     1,877    
Ending balance (in shares) at Jun. 27, 2021   69,231,197 17,635,784      
Ending balance at Jun. 27, 2021 (357,428) $ 614,496 $ 18 26,523 (4,000) (379,969)
Beginning balance (in shares) at Dec. 26, 2021   0 109,345,697      
Beginning balance at Dec. 26, 2021 653,117 $ 0 $ 109 1,129,224 0 (476,216)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (89,233)         (89,233)
Exercise of stock options (in shares) 560,610   560,610      
Exercise of stock options $ 2,927   $ 1 2,926    
Issuance of common stock related to restricted shares (in shares)     57,050      
Stock-based compensation expense 45,372     45,372    
Ending balance (in shares) at Jun. 26, 2022   0 109,963,357      
Ending balance at Jun. 26, 2022 612,183 $ 0 $ 110 1,177,522 0 (565,449)
Beginning balance (in shares) at Mar. 27, 2022   0 109,511,355      
Beginning balance at Mar. 27, 2022 626,931 $ 0 $ 110 1,152,237 0 (525,416)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (40,033)         (40,033)
Exercise of stock options (in shares)     407,452      
Exercise of stock options 2,078     2,078    
Issuance of common stock related to restricted shares (in shares)     44,550      
Stock-based compensation expense 23,207     23,207    
Ending balance (in shares) at Jun. 26, 2022   0 109,963,357      
Ending balance at Jun. 26, 2022 $ 612,183 $ 0 $ 110 $ 1,177,522 $ 0 $ (565,449)